|
Volumn 47, Issue 5, 2001, Pages 380-384
|
Preliminary study of fortnightly irinotecan hydrochloride plus cisplatin therapy in patients with advanced gastric and colorectal cancer
|
Author keywords
Cisplatin; Colorectal cancer; Fortnightly administration; Gastric cancer; Irinotecan
|
Indexed keywords
CISPLATIN;
IRINOTECAN;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ARTICLE;
ASTHENIA;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
COLORECTAL CANCER;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
GASTROINTESTINAL TOXICITY;
HOT FLUSH;
HUMAN;
LEUKOCYTE COUNT;
LEUKOPENIA;
MALE;
NEUTROPENIA;
OUTPATIENT CARE;
PRELIMINARY COMMUNICATION;
PRIORITY JOURNAL;
STOMACH CANCER;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CISPLATIN;
COLORECTAL NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0035035706
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000233 Document Type: Article |
Times cited : (27)
|
References (21)
|